<DOC>
	<DOCNO>NCT00096590</DOCNO>
	<brief_summary>RATIONALE : A test detect abnormal blood clot patient cancer may help doctor plan cancer surgery . PURPOSE : This laboratory study look new blood test detect abnormal clotting patient metastatic cancer undergo surgery .</brief_summary>
	<brief_title>Detecting Abnormal Blood Clotting Patients With Metastatic Cancer Undergoing Surgery</brief_title>
	<detailed_description>OBJECTIVES : Primary - Determine whether whole blood thrombin generation assay ( WBTGA ) detect hypercoagulability patient metastatic carcinoma compare healthy control group . - Determine whether result WBTGA change result major surgery perform patient metastatic carcinoma . - Establish reference interval WBTGA use healthy control . Secondary - Compare battery plasma component know affect reflect coagulant fibrinolytic reaction patient metastatic carcinoma vs healthy control . - Establish reference interval battery test use healthy control . - Determine major surgery cancer patient affect battery factor . - Identify change factor correlate change WBTGA . - Compare result WBTGA test patient develop venous thromboembolism ( VTE ) . OUTLINE : This pilot study . Blood sample patient collect day -7 day 1 surgery . Blood sample healthy control collect . After collection , blood sample analyze hypercoagulability whole blood thrombin generation assay . Routine blood test perform , immunoenzyme technique antigenic tissue plasminogen activator inhibitor , thrombin-antithrombin complex , tissue factor , factor VIIa , D-dimer , glycocalicin . PROJECTED ACCRUAL : A total 30 patient 30 healthy control accrue study .</detailed_description>
	<mesh_term>Thromboembolism</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Patients meet follow criterion : Diagnosis metastatic carcinoma Must enrol 1 follow surgical protocol : NCI99C0123 NCI00C0069 NCI03C0085 NCI03C0212 Healthy control participant* meeting follow criterion : No anemia thrombocytopenia No history venous thromboembolism ( deep vein thrombosis , pulmonary embolus ) No history coronary artery disease stroke No chronic inflammatory disease No diabetes mellitus Have smoke tobacco within past 6 month NOTE : * Selected basis gender age match patient accrue PATIENT CHARACTERISTICS : No symptomatic infection acute illness within past 14 day PRIOR CONCURRENT THERAPY : At least 3 day since prior drug know inhibit platelet function At least 7 day since prior acetylsalicylic acid No concurrent estrogen contraceptives hormone replacement therapy No concurrent anticoagulant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2007</verification_date>
	<keyword>thromboembolism</keyword>
	<keyword>unspecified adult solid tumor , protocol specific</keyword>
</DOC>